Mechanisms of pathogenicity in human MSH2 missense mutants - PubMed (original) (raw)
. 2008 Nov;29(11):1355-63.
doi: 10.1002/humu.20893.
Affiliations
- PMID: 18951462
- DOI: 10.1002/humu.20893
Mechanisms of pathogenicity in human MSH2 missense mutants
Saara Ollila et al. Hum Mutat. 2008 Nov.
Abstract
The human mismatch repair (MMR) gene MSH2 is the second most frequently mutated hereditary nonpolyposis colorectal cancer (HNPCC) susceptibility locus. Given that missense mutations account for 17% of all identified alterations in this gene, the study of their pathogenicity is of increasing importance. Previously, we showed that pathogenic MSH2 missense mutations typically impaired the repair activity of the protein. In this study, we took advantage of its crystal structure and attempted to correlate the mismatch binding and ATP-catalyzed mismatch release activities with the location of 18 nontruncating MSH2 mutations. We observed that the MMR-deficient mutations situated in the amino-terminal connector and lever domains of MSH2 (V161D, G162R, G164R, L173P, L187P, C333Y, and D603N) affected protein stability, whereas mutations in the ATPase domain (A636P, G674A, C697F, I745_I746del, and E749 K) mainly caused defects in mismatch binding or release. Of the MMR-proficient variants, four (T33P, A272 V, G322D, and V923E) showed slightly reduced mismatch binding and/or release efficiencies compared to wild-type (WT) protein, while two variants (N127S and A834 T) showed no defects in the assays. Similar to our biochemical data, the mutations that affected protein stability were associated with an absence of the protein in tumors in immunohistochemical (IHC) analyses. In contrast, the protein with the mutation E749 K, which abrogates MMR but not protein stability, is well expressed in tumors. In conclusion, pathogenic missense mutations in MSH2 may interfere with different mechanisms that tend to cluster in separate protein domains with varying effects on protein stability, which could be taken into account when interpreting IHC data.
(c) 2008 Wiley-Liss, Inc.
Similar articles
- Functional analysis of HNPCC-related missense mutations in MSH2.
Lützen A, de Wind N, Georgijevic D, Nielsen FC, Rasmussen LJ. Lützen A, et al. Mutat Res. 2008 Oct 14;645(1-2):44-55. doi: 10.1016/j.mrfmmm.2008.08.015. Epub 2008 Sep 4. Mutat Res. 2008. PMID: 18822302 - Two mismatch repair gene mutations found in a colon cancer patient--which one is pathogenic?
Kariola R, Otway R, Lönnqvist KE, Raevaara TE, Macrae F, Vos YJ, Kohonen-Corish M, Hofstra RM, Nyström-Lahti M. Kariola R, et al. Hum Genet. 2003 Feb;112(2):105-9. doi: 10.1007/s00439-002-0866-4. Epub 2002 Nov 21. Hum Genet. 2003. PMID: 12522549 - MSH2 missense mutations and HNPCC syndrome: pathogenicity assessment in a human expression system.
Belvederesi L, Bianchi F, Galizia E, Loretelli C, Bracci R, Catalani R, Amati M, Cellerino R. Belvederesi L, et al. Hum Mutat. 2008 Nov;29(11):E296-309. doi: 10.1002/humu.20875. Hum Mutat. 2008. PMID: 18781619 - Functional analysis helps to clarify the clinical importance of unclassified variants in DNA mismatch repair genes.
Ou J, Niessen RC, Lützen A, Sijmons RH, Kleibeuker JH, de Wind N, Rasmussen LJ, Hofstra RM. Ou J, et al. Hum Mutat. 2007 Nov;28(11):1047-54. doi: 10.1002/humu.20580. Hum Mutat. 2007. PMID: 17594722 Review. - Humanizing mismatch repair in yeast: towards effective identification of hereditary non-polyposis colorectal cancer alleles.
Aldred PM, Borts RH. Aldred PM, et al. Biochem Soc Trans. 2007 Dec;35(Pt 6):1525-8. doi: 10.1042/BST0351525. Biochem Soc Trans. 2007. PMID: 18031259 Review.
Cited by
- The hMSH2(M688R) Lynch syndrome mutation may function as a dominant negative.
Martín-López JV, Barrios Y, Medina-Arana V, Andújar M, Lee S, Gu L, Li GM, Rüschoff J, Salido E, Fishel R. Martín-López JV, et al. Carcinogenesis. 2012 Sep;33(9):1647-54. doi: 10.1093/carcin/bgs199. Epub 2012 Jun 27. Carcinogenesis. 2012. PMID: 22739024 Free PMC article. - Colon cancer associated genes exhibit signatures of positive selection at functionally significant positions.
Morgan CC, Shakya K, Webb A, Walsh TA, Lynch M, Loscher CE, Ruskin HJ, O'Connell MJ. Morgan CC, et al. BMC Evol Biol. 2012 Jul 12;12:114. doi: 10.1186/1471-2148-12-114. BMC Evol Biol. 2012. PMID: 22788692 Free PMC article. - Verification of the three-step model in assessing the pathogenicity of mismatch repair gene variants.
Kansikas M, Kariola R, Nyström M. Kansikas M, et al. Hum Mutat. 2011 Jan;32(1):107-15. doi: 10.1002/humu.21409. Hum Mutat. 2011. PMID: 21120944 Free PMC article. - Assessing pathogenicity: overview of results from the IARC Unclassified Genetic Variants Working Group.
Tavtigian SV, Greenblatt MS, Goldgar DE, Boffetta P; IARC Unclassified Genetic Variants Working Group. Tavtigian SV, et al. Hum Mutat. 2008 Nov;29(11):1261-4. doi: 10.1002/humu.20903. Hum Mutat. 2008. PMID: 18951436 Free PMC article. No abstract available. - Oligonucleotide-directed mutagenesis screen to identify pathogenic Lynch syndrome-associated MSH2 DNA mismatch repair gene variants.
Houlleberghs H, Dekker M, Lantermans H, Kleinendorst R, Dubbink HJ, Hofstra RM, Verhoef S, Te Riele H. Houlleberghs H, et al. Proc Natl Acad Sci U S A. 2016 Apr 12;113(15):4128-33. doi: 10.1073/pnas.1520813113. Epub 2016 Mar 7. Proc Natl Acad Sci U S A. 2016. PMID: 26951660 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases